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Abstract
Appropriate maintenance and regeneration of adult endocrine organs is important in both normal physiology and
disease. We investigated cell proliferation, movement and differentiation in the adult mouse adrenal cortex, using
different 5-bromo-2'-deoxyuridine (BrdU) labelling regimens and immunostaining for phenotypic steroidogenic cell
markers. Pulse-labelling showed that cell division was largely confined to the outer cortex, with most cells moving
inwards towards the medulla at around 13-20 µm per day, though a distinct labelled cell population remained in the
outer 10% of the cortex. Pulse-chase-labelling coupled with phenotypic immunostaining showed that, unlike cells in
the inner cortex, most BrdU-positive outer cortical cells did not express steroidogenic markers, while co-staining for
BrdU and Ki67 revealed that some outer cortical BrdU-positive cells were induced to proliferate following acute
adrenocorticotropic hormone (ACTH) treatment. Extended pulse-chase-labelling identified cells in the outer cortex
which retained BrdU label for up to 18-23 weeks. Together, these observations are consistent with the location of
both slow-cycling stem/progenitor and transiently amplifying cell populations in the outer cortex. Understanding the
relationships between these distinct adrenocortical cell populations will be crucial to clarify mechanisms underpinning
adrenocortical maintenance and long-term adaptation to pathophysiological states.
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Introduction
The adult adrenal cortex consists of three principal
concentric morphological zones, surrounding a central medulla,
distinguished by their cellular organisation and steroid hormone
products (reviewed in 1). The outer zona glomerulosa (ZG)
located just beneath the surrounding mesenchymal capsule
contains ovoid cells, arranged into arch-like structures
surrounding capillary glomeruli, that synthesise the
mineralocorticoid aldosterone. The intermediate zona
fasciculata (ZF) is made up of cuboid glucocorticoid-
synthesising cells organised in columnar bundles (or fascicles)
separated by radial open-pore capillary sinusoids, while cells of
the inner zona reticularis (ZR) are embedded in a condensed
‘reticulum’ of interconnecting blood vessels and connective
tissue. In most mammals the ZR is defined morphologically, but
in humans and some primates it serves the specialised function
of making C19 adrenal androgens. In rats and some other
species, an additional morphologically-distinct zone, the zona
intermedia (ZI), has been described at the boundary between
the ZG and ZF ([2] and references therein). In the rat, this has
subsequently been termed the ‘undifferentiated zone’ (ZU)
because, although cells in this region express some
steroidogenic enzymes (e.g. steroid 21-hydroxylase; 21-OH;
approved symbol Cyp21a1), they do not express either the ZG-
specific aldosterone synthase (AS; approved symbol Cyp11b2)
or the ZF-specific 11β-hydroxylase (11β-OH; approved symbol
Cyp11b1) [2]. Others have argued, however, that these ZI/ZU
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cells are part of the ZG, which thus comprises a mixture of both
terminally differentiated steroidogenic cells and cells with a less
differentiated, more plastic phenotype [3].
Steroidogenic cells of the different adrenocortical zones are
thought to originate from one or more self-renewing
populations of undifferentiated somatic stem cell progenitors,
located somewhere in the outer region of the gland or within
the capsule [1,4]. Although cells can divide in all three cortical
zones, experimental evidence from rats suggests that under
normal physiological conditions most cell proliferation occurs in
the outer cortex, after which cells move inwards and are
eventually eliminated by apoptosis close to the medulla
boundary [5–10].
Radial mosaic patterns in adrenal cortices of chimeric and
transgenic mosaic rats and mice [11–16] and radial labelled
clones in mice expressing transgenic lineage markers [17]
suggest a clonally-related origin for cells of all three
adrenocortical zones. It remains possible, however, that
different zones could be maintained by separate, radially-
aligned stem cell populations that share a common
developmental origin [18]. Also, experimental manipulations
leading to zone-specific hypertrophy and hyperplasia [2,19,20]
and steroidogenic enzyme expression [2,21,22] show that that
adaptive responses of the mature adrenocortical zones must
be autonomous to allow independent regulation of
mineralocorticoid and glucocorticoid steroid hormone
production.
There is now considerable evidence that resident
populations of relatively undifferentiated adult (somatic) stem
cells play essential roles in maintaining many highly
regenerative tissues (reviewed in 23,24). The key features of
adult stem cells are that they are long-lived, relatively
undifferentiated and usually divide asymmetrically, both to self-
renew and produce more differentiated cell types. They are
also typically slow-cycling and can enter periods of quiescence
so that, while stem cells have unlimited proliferative potential,
they usually divide relatively infrequently unless the host organ
is subject to injury or physiological stress. Many stem cells
produce an intermediate cell type, termed transient (or transit)
amplifying cells (TACs), which have a lower proliferative
potential than a stem cell but typically cycle more rapidly and
divide a limited number of times, giving rise to progressively
more differentiated offspring. TACs thereby generate a clonal
cell lineage of post-mitotic, functionally differentiated cells to
replace older and damaged parenchymal cells. The nature and
location of putative adult stem/progenitor cells maintaining the
adult adrenal cortex have yet to be identified definitively
(reviewed in 1,4). However, similar to other tissues, it seems
probable that the adrenocortical zones are maintained by co-
ordinate regulation of cell division, movement and
differentiation in response to different physiological stimuli.
Cell division, cell movement and the location of putative
somatic stem cells can be monitored using chromatin-labels,
such as the thymidine analogue 5-bromo-2'-deoxyuridine
(BrdU) or H2B-GFP, which are incorporated into the DNA of
cells undergoing division [24]. Thus, actively dividing cells can
be identified with a single BrdU injection (‘pulse’-labelling),
while subsequent cell movement is monitored by BrdU ‘pulse-
chase’-labelling (BrdU pulse-labelling, followed by various
‘chase’ periods in the absence of BrdU). However, longer
labelling and chase periods are needed to identify cells that
divide and take up label only infrequently and then retain it by
cycling slowly or becoming quiescent (long term BrdU ‘label-
retaining cells’; LRCs). LRCs can be distinguished from other
cells taking up label but continuing to cycle rapidly, as in the
latter case the label quickly becomes ‘diluted’ below the level of
detection. One drawback is that not all LRCs are stem cells,
since cells that take up label during the last division prior to
terminal differentiation will also remain labelled. However, in
many tissues, labelled stem cells can be distinguished from
differentiated LRCs, because they are non-migratory, do not
express genes characteristic of more differentiated cell types
and can re-enter the cell cycle and proliferate in response to
appropriate physiological stimuli. Thus, in principle, stem cell
location can be inferred by tracking the movement of
differentiated LRCs in relation to undifferentiated LRCs at their
point of origin. Indeed, label retention combined with lineage
tracing and clonogenicity assays, has proved remarkably
successful for identifying adult stem cells in many tissues [24].
Tritiated thymidine and BrdU pulse-chase labelling have
been used previously to show that cell proliferation occurs
principally in the outer ZI region of the adult rat adrenal cortex,
after which the majority of cells move inwards towards the
medulla [5–7]. These techniques have yet to be applied
systematically to the mouse where, in the absence of a defined
ZI, it is not yet clear whether cell movement following division is
predominantly centripetal, or if the adult mouse adrenal cortex
has long term LRCs that could be candidate stem cells [18].
Therefore, the principal aims of this study were to combine
BrdU pulse-chase labelling with immunostaining for phenotypic
steroidogenic enzyme markers (i) to identify cell division
patterns and the rate and direction of adult adrenocortical cell
movement; (ii) to assess different stages of cell differentiation
in the adrenocortical zones; (iii) to distinguish slow-cycling and
terminally differentiated BrdU-labelled adrenocortical cell
populations by assessing whether or not they are able to
proliferate following acute trophic stimulus and (iv) to determine




All the animal work in this study was approved by the
University of Edinburgh Ethical Review Committee
(applications PL64-02 and PL21-06) and performed in
accordance with institutional guidelines and UK Home Office
regulations under project license numbers PPL 60/2887 and
PPL 60/3635. All surgery was performed under general
anaesthesia and all efforts were made to minimise suffering.
Mice
Wild-type (C57BL/6 x CBA/Ca)F1 hybrid mice (hereafter
abbreviated to F1) were bred and maintained in the Biological
Research Facility, University of Edinburgh and killed by cervical
dislocation following inhalation of gaseous anaesthetic.
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BrdU labelling and ACTH treatment
For studies of adrenocortical cell movement, 12-week-old F1
mice were given single i.p. BrdU injections (10mg BrdU/ml
saline; 0.2ml/mouse) and then killed four hours later or left for
various chase periods before tissue collection. For acute
adrenocorticotropic hormone (ACTH) treatment, female F1
mice were pulse-chase-labelled by 1-week infusion of BrdU
(50mg BrdU/ml saline; 0.1ml/mouse; Alzet osmotic mini-pump
model 1007D) followed by a 6-week chase. Mice (n = 6) were
then injected with ACTH (Synacthen, Alliance Pharmaceuticals,
UK; 12.5 IU/ kg) or vehicle (0.9% saline) and killed 4 hours
later, when the proliferative response to ACTH should be
maximal [25]. For identification of LRCs, 12 week old F1 mice
were infused with BrdU for 1 week (50mg BrdU/ml saline;
0.1ml/mouse; Alzet osmotic mini-pump model 1007D) or 2
weeks (50mg BrdU/ml saline; 0.2ml/mouse; Alzet osmotic mini-
pump model 2002) and killed immediately or left for various
chase periods.
Tissue processing and immunostaining
Adrenal glands were fixed in either 4% paraformaldehyde (4
h) in PBS at 4°C for BrdU immunostaining, or 4% neutral
buffered formalin (24 h) for dual-immunostaining and
immunofluorescence. Fixed adrenals were paraffin wax-
embedded, cut and longitudinal 7-10 µm mid-sections mounted
on polysine microscope slides.
For BrdU immunostaining, sections were dewaxed in xylene,
washed in ethanol and immersed in 3% hydrogen peroxide in
methanol for 30 min at RT to block endogenous peroxidase
activity. Sections were then rehydrated in 70% ethanol, washed
in PBS, and subjected to heat-induced epitope retrieval (HIER).
After blocking in 20% normal rabbit serum in TBS for 30 min,
sections were immunostained using a mouse monoclonal anti
BrdU antibody (Becton Dickinson, 347580; 1:200), followed by
a biotinylated rabbit anti-mouse second antibody (Dako,
E0354; 1:200) and then avidin-biotin horseradish peroxidase
(HRP) (Dako, K0355; 1:1000) using the 3,3′-Diaminobenzidine
(DAB) isopac system as substrate (Sigma, D9015). Sections
were finally lightly counterstained with haematoxylin.
BrdU/Ki67 dual-immunostaining was carried out after
dewaxing, blocking and HIER as described above, using a
sheep polyclonal anti-BrdU antibody (Fitzgerald Industries, 20-
BS17; 1:7000), followed by a biotinylated rabbit anti-sheep
second antibody (Vector Labs, BA-6000; 1:500) and
streptavidin-alkaline phosphatase (Dako, D0396; 1:1000) using
Fast Blue (Sigma, F3378; 1mg/ml in 0.1M Tris buffer, pH8.0)
as substrate. After further HIER, Ki67 was detected using a
monoclonal mouse antibody (Novocastra, NCL-Ki67-MM1;
1:250), followed by a biotinylated rabbit anti-mouse secondary
antibody (Dako, E 0464; 1:500) and staining with streptavidin-
HRP-DAB. For clarity, fast blue-stained sections were mounted
without counterstaining.
Dual-immunofluorescent-staining was adapted from [26],
using a Vision Biosystems Bond max staining robot. Sections
prepared as described above were blocked in 20% normal goat
serum in TBS Tween (TBST). AS and CD31 were detected
using rabbit polyclonal antibodies for AS (Celso Gomez-
Sanchez, Jackson, USA; 1:100) and CD31 (Abcam, ab28364;
1:1000), followed by goat anti-rabbit peroxidase Fab (Abcam,
ab97200; 1:500) and then Tyramide Cy3 (Perkin Elmer). 21-
OH was detected by incubating sections first in Rodent Block
M, followed by a mouse monoclonal 21-OH antibody (Celso
Gomez-Sanchez, Jackson, USA; 1:2000) and Mouse on
Mouse Polymer (Abcam, ab127055), and Tyramide Cy3
(Perkin Elmer). For dual-BrdU staining, all sections were
subjected to HIER using Bond ER1 retrieval buffer (Leica
Microsystems), blocked in 20% normal rabbit serum in TBST
for 30 mins and immunostained with sheep polyclonal anti-
BrdU antibody (Fitzgerald Industries, 20-BS17; 1:10,000),
followed by rabbit anti-sheep peroxidase (Source Bioscience;
1:500) and Tyramide Cy5 (Perkin Elmer). Finally, sections were
mounted using Permafluor (Thermo Scientific) and examined
under a Zeiss LSM510 metaconfocal microscope.
Quantitative analysis of BrdU-labelled and Ki67-
positive cells
Immunostained adrenal sections were examined with a Zeiss
Axioskop 2 compound microscope and calibrated digital
images captured with a Nikon Coolpix 995 or JVC 3CCD digital
camera, using KS 300 or MCID digital imaging software
(Imaging Research Inc).
Following single BrdU injection, positions of individual
labelled cells were determined on calibrated digital images of
BrdU-stained adrenal sections using ImageJ software [27].
Measurement along the shortest straight line between the outer
capsule and the cortical-medulla boundary, passing through
the position of a labelled cell was used to determine its
distance from both boundaries. To allow for variations in
cortical thickness, measured distances of labelled cells from
the capsule were then converted to a percentage of the total
capsule-medulla distance.
Following ACTH treatment, cells with BrdU-positive, Ki67-
positive or BrdU/Ki67-dual-labelled or unlabelled nuclei were
counted manually in ZG, outer ZF, inner ZF and ZR fields in
digital images of BrdU/Ki67-dual-immunostained adrenal
sections. Four sections from left adrenals of 6 control and 6
ACTH-treated female F1 mice were analysed by a single
observer who was blinded to treatment. Cells displaying a
typically elongated endothelial cell nuclear morphology [28]
were excluded from the analysis. Mean percentages (±SEM) of
total labelled and unlabelled nuclei numbers were calculated
for each zone and treatment. Cell size was estimated by
dividing field area by the total number of nuclei within the field
(150-200 cells).
After 1 or 2-weeks of BrdU infusion, followed by various
chase periods, BrdU-labelled cell numbers were counted in
calibrated digital images of adrenocortical sections by
superimposing a 10x10 grid on the image to span the full
thickness of the cortex. The number of BrdU-labelled cells were
then counted separately in each of the 10 grid rows (from the
outside of the capsule to the cortical-medulla boundary), using
ImageJ. To allow for variations in cortical thickness, data
collection was restricted to cortical regions which were between
330-400µm thick and where the flanking adrenal capsule was
approximately parallel to the cortical-medullary boundary. BrdU
Maintenance of the Adult Mouse Adrenal Cortex
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cell counts scored cells as labelled or unlabelled and did not
asses variations in staining intensity.
Statistical analysis
Statistical tests (Student’s t-test and χ2 test with Yates
correction) were performed using Microsoft Excel, StatView
(SAS Institute Inc.) or GraphPad Prism (GraphPad Software
Inc.). Data were analysed for the effects of ACTH treatment on
BrdU-positive, Ki67-positive, BrdU/Ki67-dual-labelled and
unlabelled nuclei, using a General Linear Model of ANOVA
(Minitab software v12), to take account of any variability
between sections and adrenal glands.
Results
Dynamics of cell proliferation and movement in the
adult adrenal cortex
To define the main proliferative region in the mouse adrenal
cortex, locations of cells labelled by single BrdU injection were
examined in left adrenals of 12-week-old female F1 mice
(Figures 1 and 2). Four hours after BrdU injection, most
labelled cells (147/153 = 96%) were in the outer 40% of the
cortex (Figures 1A and 2A). This is also seen as a change in
slope of the cumulative frequency graph at around 40% of the
distance from the capsule (Figure 2E). Therefore, the outer
40% of the cortex was classified as the ‘high proliferative
region’ while the remainder (over 40% of the distance from the
outside of the capsule to the medulla) was designated the ‘low
proliferative region’. Within the outer high proliferative region,
the main area of cell proliferation was concentrated at 5-25% of
the distance from the outside of the capsule (112/147 cells =
76%).
To assess mouse adrenocortical cell movement, locations
and BrdU pulse-labelled cell numbers were compared at 4 h
and 1 week after single BrdU injection (Figures 1A and 2A vs.
Figures 1B and 2B). This showed that over this period the
mean number of BrdU-labelled cells per section did not
change, (45.7±5.2 at 1 week vs. 51.0±5.5 at 4 h; P = 0.522; t-
test). However, a significantly higher proportion of labelled cells
were located in the inner, low proliferative region (21.2% at 1
week vs. 3.9% at 4 h; χ2 = 18.67; P < 0.0001), implying that
cells had moved from the outer, high proliferative region
towards the medulla. The frequency of labelled cells within the
outer 10% of the cortex did not change significantly during the
first week (29.2% at 1 week vs. 20.9% at 4 h.; χ2 = 2.23; P >
0.05). Nevertheless, there were significantly more labelled cells
within 5% of the outside of the capsule (20.4% at 1 week vs.
5.2% at 4 h.; χ2 = 14.01; P = 0.0002), suggesting that local
outward cell movement occurred within the outer 10% of the
cortex. This trend for increased BrdU-positive cell numbers in
the outer 5% of the cortex after 1 week is also shown by the
cumulative percentage plots (Figure 2E) and was maintained at
3 weeks, but is reduced by 5 weeks. Thus, while most BrdU-
labelled cells move inwards from the proliferative region
towards the medulla, some cells in the outer 10% of the cortex
appeared to move in the opposite direction, towards the
capsule.
To estimate the rate of inward adrenocortical cell movement
towards the medulla, the distances from the capsule of labelled
cells closest to the medulla were compared at 4 hours (216
µm) and 1 week (337 µm) after single BrdU injection, after
taking account of differences in cortex thickness by conversion
to percentage distances from the capsule (61.5% and 85.1%
respectively). This represents a difference of 23.6% of the total
distance. The mean distance (±SEM) between the capsule and
medulla was determined as 399±2.9 µm for all the adrenals
analysed (397±4.5 µm for just those analysed at 4 hours and 1
week after BrdU injection), so a movement of 23.6% of this
distance represents a movement of approximately 94 µm in 1
week (13.5 µm per day). One problem with estimating the rate
of movement of cell closest to the medulla is that positions of
BrdU-labelled cells in the low proliferative region were quite
variable (Figure 2A, B). Therefore a second estimate was
made closer to the 90th centile of the labelled cells, using the
positions of the 5 BrdU-labelled cells located closest to the
medulla, after first excluding the 10% of labelled cells nearest
to the medulla. The mean (and percentage) of these 90th
centile cells from the capsule were 139 µm (30.5%) at 4 hours
and 238 µm (65.9%) at 1 week after BrdU injection. The
percentage difference of 35.4% represents a distance moved
of approximately 141 µm per week (20.1 µm per day). Overall,
these two estimates suggest an approximate rate of
adrenocortical cell movement of 13-20 µm per day. If cells in
different parts of the cortex move at different rates, these will
be estimates of the maximum rate of movement, because they
are based on the leading groups of cells.
BrdU pulse-chase labelled cells in the outer cortex lack
steroidogenic markers
Three weeks following single BrdU injection, labelled cells
had spread inwards through the cortex from the high
proliferative region (Figure 2C) and by 5 weeks were more
evenly distributed with some approaching the cortical-medulla
boundary (Figure 2D). Based on this and other preliminary data
(Figure S1), immunostaining for steroidogenic and vascular
endothelial cell markers was combined with a 1 week BrdU
pulse followed by 6 weeks chase to analyse the differentiation
state of labelled cells in specific adrenocortical zones (Figure
3). BrdU/21-OH dual immunoflourescence showed, as
expected, that cells expressing 21-OH, required for synthesis
of all three major adrenocorticosteroid classes, were distributed
throughout the adrenal cortex (Figure 3A,B), with clusters of
weakly stained 21-OH-positive cells in the ZG showing a
similar distribution to AS positive cells (Figure 3C). However,
most BrdU-labelled cells in the outer cortex did not express 21-
OH, while most inner cortical BrdU-labelled cells were positive
for 21-OH. AS immunostaining was restricted to arch-like
clusters of cells in the ZG though, as might be expected under
normal dietary sodium conditions, not all morphologically
identifiable ZG cells expressed AS (Figure 3C). The ZG also
contained scattered BrdU-labelled cells around the capsule-ZG
junction, most of which did not express AS, while most AS-
positive cells in the ZG were BrdU-negative (Figure 3C,D). The
possibility that much of the BrdU label in the outer cortex might
reside in cortical vasculature cells is ruled out by dual-
Maintenance of the Adult Mouse Adrenal Cortex
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immunostaining for BrdU and CD31, a vascular endothelial cell
marker [29]. This showed that large round BrdU-labelled nuclei
typical of steroidogenic cells were CD31 negative, while very
few CD31-postive cells had BrdU-labelled nuclei (Figure 3E,F).
Together, these dual-BrdU/steroidogenic marker-
immunostaining results suggest that the majority of BrdU pulse-
chase-labelled cells in the outer adrenal cortex lack a
differentiated steroidogenic phenotype.
Response of BrdU pulse-chase-labelled adrenocortical
cells to acute ACTH stimulation
To distinguish between slow-cycling and terminally
differentiated cells in specific adrenocortical zones, BrdU pulse-
chase-labelled cells were assessed for their ability to proliferate
following acute ACTH stimulation, by dual-staining for BrdU
and Ki67. This showed that 4 hours after ACTH treatment,
BrdU-labelled cells remained widely distributed throughout the
adrenal cortex, but nuclei positive for the Ki67 cell proliferation
marker were found mostly in the outer cortex (Figure 4).
Quantitative analysis showed that BrdU-labelled cell numbers
showed a moderate increase in the ZG and outer and inner ZF
Figure 1.  BrdU pulse-labelled cells in adult mouse adrenal glands.  (A-D) BrdU immunostaining of adrenal sections from
female F1 mice (A) 4 hours; (B) 1 week; (C) 3 weeks & (D) 5 weeks after a single BrdU injection. Typical BrdU-labelled cells (brown
nuclei) are indicated by arrows. (a-d) Higher magnification views of BrdU-positive nuclei that are shown in A-D. Scale = 100 µm in
A-D; 50 µm in a-d.
doi: 10.1371/journal.pone.0081865.g001
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following ACTH treatment, while Ki67-positive cells were
increased significantly in the outer ZF (Figure 5A-B). Crucially,
BrdU/Ki67 dual-labelled cell numbers showed a statistically
significant increase in the ZG, with a similar, but non-significant
Figure 2.  Distribution of single injection BrdU pulse-labelled cells in adult mouse adrenal glands.  For quantitative analysis,
BrdU-labelled cells were counted in left adrenal mid-sections from 3 mice per group and their positions measured, as described in
the Materials and Methods section. Labelled cell numbers per section (mean±SEM) were respectively A. 51.0±5.51; B. 45.7±5.24;
C. 37.0±7.94 and D. 48.0±9.07. Cell positions, expressed as the percentage of the radial depth of the cortex from the capsule, were
grouped into 20 locations (X-axis in A-D). Unlabelled cells were not counted, so the frequency of labelled cells in each location is
expressed as a percentage of all the labelled cells in the section (Y-axis). Grey bars, <40% distance from the outside of the capsule
(high proliferative region); black bars, ≥40% distance (low proliferative region). (E) Semi-log cumulative percentage plot of results
shown in A-D to focus on cell distributions in the outer 10% of the cortex.
doi: 10.1371/journal.pone.0081865.g002
Maintenance of the Adult Mouse Adrenal Cortex
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Figure 3.  Location of BrdU-pulse-chase-labelled and steroidogenic cells in the adult adrenal cortex.  Dual-
immunofluorescent staining of adrenal sections from female F1 mice for (A,B) BrdU (green)/21-OH (red); (C,D) BrdU (blue)/AS
(green); (E,F) BrdU (blue)/CD31(green), after 1-week BrdU labelling and 6-week chase, as described in the Materials and Methods
section. Clusters of weakly staining 21-OH-positive ZG cells near the top in A,B show similar distribution to AS-positive cells in C,D.
Scale A,C,E = 100 µm; B,D,F = 20 µm.
doi: 10.1371/journal.pone.0081865.g003
Maintenance of the Adult Mouse Adrenal Cortex
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(P = 0.14), increase in the outer ZF (Figure 5C). Cell
proliferation in response to ACTH was not affected by prior
BrdU labelling, since the proportions of Ki67-positive cells did
not differ significantly between BrdU-labelled and unlabelled
cells in any of the zones before and after ACTH treatment (P >
0.1), while acute ACTH-treatment had no significant effect on
cell size (average cross-sectional area) in any zone (data not
shown).
Identification and distribution of label-retaining cells in
the adult mouse adrenal cortex
Two experiments were undertaken to determine if long term
LRCs are present in the adult mouse adrenal cortex, first to
optimise the BrdU-pulse-chase period and second to identify
LRCs. In a preliminary experiment, 12-week old female F1
mice were infused with BrdU for 1 week, after which the
locations of labelled cells in left adrenal glands were examined
immediately, or following ‘chase’ periods of 5, 7, 12 and 15
weeks (one mouse per chase period). As expected from the
previous single-injection experiment (Figures 1 and 2), most
labelled cells were located in the outer cortex immediately
following a one-week BrdU infusion (Figures S1 and S2).
Following a 5-week chase period, labelled cells had spread to
the inner cortex and overall BrdU labelled cell numbers had
increased slightly, perhaps indicating that some cells had
divided at least once more following incorporation of BrdU.
With longer chase periods (7, 12 & 15 weeks; Figures S1 and
S2) frequencies of BrdU-labelled cells declined, but even after
15 weeks labelled cells remained relatively abundant and were
not restricted to a specific region, implying that longer chase
times would be required to identify LRCs in the adrenal cortex.
Therefore, to address the requirement for longer chase times
and to ensure that a greater number of potential LRCs were
labelled, in a second experiment 12-week old female F1 mice
were infused with BrdU for 2-weeks and the locations of
labelled cells in left adrenal glands examined immediately or
following different ‘chase’ periods. A 6-week chase period was
used to confirm that labelled cell distributions followed those
seen in the preliminary experiment (Figures S1 and S2), after
which 18 and 23 week chase periods were used to identify
LRCs. (BrdU pulse-chase-labelled cells in male left adrenal
glands showed similar distributions to females and were not
analysed quantitatively.) Again, large numbers of BrdU-labelled
cells were detected immediately after the infusion period, being
located mainly in the outer cortex (Figure 6A,E). After a 6-week
chase period, labelled cells had spread through most of the
cortex (Figure 6B,F), consistent with the preliminary
experiment, though, subjectively, BrdU staining intensity
seemed weaker in some cells. Between 6- and 18-week chase
periods the overall frequency of BrdU-labelled cells fell
significantly from 37.9% to 14.2% (P = 0.002; t-test). Following
an 18-week chase period most BrdU-labelled cells were
located either in the outer cortex, often clustered near the
capsule, or in the inner cortex close to the medulla; with fewer
labelled cells in the middle of the cortex (Figure 6C,G). A few
labelled cells also persisted within the medulla. Following a 23-
week chase period, the proportion of BrdU-labelled cells in the
cortex fell further to 6.1%, which was significantly less than the
18-week frequency (P = 0.007; t-test). At this stage, while the
majority of remaining BrdU-labelled cells were located in the
inner cortex (Figure 6H), there were still a few strongly-staining
BrdU-positive cells located mainly close to or in the capsule
(Figure 6D). Subjectively, most of the cells retaining a BrdU
label in the inner cortex were less strongly-stained than those
near the capsule.
Discussion
In this study, we have attempted to characterise some of the
mechanisms involved in adult adrenocortical tissue
maintenance by analysing patterns of cell proliferation,
movement and differentiation in the adult mouse adrenal
cortex.
Cell proliferation and movement
Single BrdU injection showed that cell proliferation occurred
primarily in the outer 40% of the adrenal cortex, with the main
proliferative area concentrated at 5% to 25% from the capsule,
encompassing the boundary between the ZG and ZF. This is
consistent with previous reports in the rat [5–7] and whole-
organ labelling in mouse [30]. However, the rate for mouse
adrenocortical inward cell movement, of 13-20 µm per day,
reported here is greater than that estimated for the rat, which
equates to 2.6-5.0 µm per day [6]. This difference may be
partly methodological, because we compared locations of cells
that were closest to the medulla or at the 90th centile at 4 h and
1 week after pulse-labelling, instead of mean or median
positions of labelled cells over longer intervals. Therefore, our
estimate will be close to a maximum rate for adrenocortical cell
movement, but should minimise errors occurring over longer
periods due to increases in labelled cell numbers due to further
cell division followed by losses due to label dilution or cell
death, and the confounding effects of outward movement in the
ZG (discussed below). As far as we are aware, this is the first
quantitative estimate of the rate of inward cell movement in the
mouse adrenal cortex.
One week after BrdU pulse-labelling most labelled cell
movement was towards the medulla but there was also
evidence that a minor cell population remained in the outer
10% of the cortex, perhaps moving outwards towards the
capsule. Thus, separate TAC populations may replenish the
ZG and ZF/ZR. As mentioned previously, distributions of
labelled cells over longer periods are more difficult to interpret
due to concomitant cell division, movement and cell death.
However, persistence of labelled cells in the outer 5% of the
cortex at 3 weeks followed by a reduction at 5 weeks could
indicate either the presence of specific progenitors that
continue to divide or the elimination of terminally differentiated
ZG cells by apoptosis or redistribution to the inner cortex
following transdifferentiation.
Adrenocortical cell phenotypes
Under basal conditions six weeks after 1-week BrdU
infusion, less than 10% of BrdU-labelled cells in all zones were
BrdU/Ki67 dual-labelled, implying that most proliferating cells
incorporating BrdU during 1-week pulse then either cycled
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Figure 4.  Effect of acute ACTH treatment on BrdU-pulse-chase-labelled cells in the adult mouse adrenal cortex.  Adrenal
sections from female F1 mice treated acutely with ACTH 6 weeks after 1-week BrdU infusion, immunostained for (A,B) BrdU, (C,D)
Ki67 and (E,F) BrdU/Ki67. Mice (n =6/group) were injected with saline vehicle (A,C,E) or ACTH (B,D,F), as described in the
Materials and Methods section. Ki67-positive cells are indicated by brown nuclear staining while BrdU-labelled cells are identified by
blue nuclear staining. Typical examples of BrdU/Ki67 dual-labelled cells are shown by arrows in F. Sections C and D were lightly
counterstained with haematoxylin but sections A,B,E & F were mounted without counterstaining. Scale = 100 µm.
doi: 10.1371/journal.pone.0081865.g004
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Figure 5.  Effect of acute ACTH treatment on BrdU pulse-chase-labelled cell numbers in the adult mouse adrenal
cortex.  BrdU and Ki67-labelled cell numbers in control and 4 h ACTH treatment groups (n=6) of female F1 mice, treated 6 weeks
after 1-week BrdU infusion. Mean percentage (±SEM) of total cell numbers are shown for each zone and treatment that were (A)
BrdU-positive/Ki67-negative, (B) BrdU-negative/Ki67-positive, (C) BrdU-positive/Ki67-positive (dual-labelled) and (D) BrdU-negative/
Ki67-negative (unlabelled). Cells were counted in ZG, outer ZF, inner ZF and ZR in dual-BrdU/Ki67-immunostained left adrenal
sections, as described in the Materials and Methods section.
doi: 10.1371/journal.pone.0081865.g005
Maintenance of the Adult Mouse Adrenal Cortex
PLOS ONE | www.plosone.org 10 December 2013 | Volume 8 | Issue 12 | e81865
Figure 6.  Distribution of BrdU pulse-chase-labelled cells in the adult mouse adrenal cortex following different chase
periods.  (A-D) BrdU immunostaining of adrenal sections from female F1 mice, (A) 4 hours (n=2), (B) 6 weeks (n=2), (C) 18 weeks
(n=3) and (D) 23 weeks (n=5) following 2-week BrdU infusion. Arrows in C,D indicate examples of labelled cells, which at 18 weeks
were often clustered near the capsule. Scale = 100 µm. (E-H) Labelled cell distributions are shown as mean percentage (±SEM) of
BrdU-positive cells in each of 10 sampling rows across the depth of the cortex (as a percentage of all the cells in the row), in left
adrenal sections. Sampling positions 1-10 were rows 1-10 of a 10x10 sampling grid with row 1 including the capsule and row 10
being closest to the medulla, as described in the Materials and Methods section.
doi: 10.1371/journal.pone.0081865.g006
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slowly or underwent terminal differentiation and withdrew from
the cell cycle during the six week chase. Most BrdU-labelled
cells located in the inner cortex were also positive for 21-OH
(expressed in all steroidogenic cells of the adrenal cortex),
suggesting that they might be steroidogenic cells which had
taken up label prior to terminal differentiation. In contrast, the
majority of BrdU-labelled cells in the outer cortex expressed
neither 21-OH nor AS (normally expressed exclusively in ZG
steroidogenic cells), showing that they were relatively
undifferentiated. A further probe of cell phenotype by acute (4
h) ACTH treatment produced a moderate increase in total
BrdU-labelled cell numbers in the ZG and throughout the ZF,
suggesting division of previously-labelled cells, but total Ki67-
positive cell numbers showed a significant increase only in the
outer ZF, but not in the ZG or inner ZF. However, BrdU/Ki67
dual-labelled cell numbers were increased significantly in the
ZG following ACTH treatment, with a similar trend in the outer
ZF. This suggests (i) that the proliferative response to acute
ACTH treatment is mainly confined to the previously-identified
high proliferative region in the ZG and outer ZF and (ii) that
some of BrdU-labelled cells in this region (labelled during
proliferation 6 weeks previously, followed by slow-cycling or
terminal differentiation) had been induced to proliferate by
acute ACTH treatment and become Ki67-positive (current
proliferation). This is consistent with the idea that the ZG may
contain slow-cycling stem or progenitor cells that are activated
in response to physiological stimulus.
As most ZF cells express 21-OH, the majority of Ki67-
positive cells in the outer ZF are likely to be partially
differentiated TACs, rather than stem or progenitor cells. Also,
the increase in Ki67-positive cell numbers following acute
ACTH treatment is consistent with an expansion in TAC
numbers. ACTH treatment also caused a significant increase in
BrdU-labelled cells in the inner ZF, apparently in the absence
of increased cell proliferation. Since, most BrdU-labelled cells
in the inner ZF also express 21-OH, they are unlikely to be
stem/progenitors or TACs but, rather, they may be fully
differentiated ZF cells which incorporated BrdU label earlier
during terminal differentiation and moved inwards. Meanwhile
the ACTH-induced increase in BrdU-labelled cell numbers
might be explained by increased cell proliferation in the outer
ZF and further inward displacement of labelled terminally
differentiated cells.
Identification of label-retaining cells in the outer
adrenal cortex
The observation of two groups of BrdU-labelled cells at 18
and 23 weeks following 2-week BrdU infusion, demonstrates
the presence of long term LRCs in the mouse adrenal cortex.
LRCs in the outer cortex stained strongly for BrdU but were
relatively few in number and located mainly close to or within
the capsule. It seems unlikely that these LRCs could be
steroidogenic ZG cells which incorporated label during terminal
differentiation, because, as noted previously, six weeks after
BrdU-pulse-chase labelling most labelled cells in the outer
cortex lacked a differentiated steroidogenic phenotype.
Therefore, these LRCs may be candidates for slowly cycling
adrenocortical stem or progenitor cells. However, additional
experiments will be required to determine if they correspond to
the subpopulation of BrdU-pulse-chase-labelled cells in the ZG
that respond to acute ACTH stimulation by proliferating. The
second, less-strongly-staining group of LRCs located in the
inner cortex close to the medulla boundary, are probably the
last of the inwardly moving cells with their origin in TACs which
had divided and incorporated label during the 2-week BrdU
pulse, perhaps then undergoing one or two further cell divisions
before terminally differentiating and moving inwards towards
the medulla during the chase period. It seems unlikely on
morphological grounds that these LRCs are located within a
persistent X zone and also because female mice were infused
with BrdU from 12 to 14 weeks of age when little or no cell
division occurs within the X zone [31].
Stem/progenitor cell maintenance of the adult mouse
adrenal cortex
Most adult stem cells characterised to date are non-
migratory, lack the differentiated hallmarks of the host tissue
and typically cycle slowly, but are able to proliferate in
response to physiological stimuli, giving rise to lineage-
committed progenitor cells. Experiments presented here using
different pulse-chase regimens have identified cell populations
in the adult mouse adrenal cortex matching some criteria for
putative stem/progenitor cells. Data also support the existence
of Ki67-positive, partly differentiated cells in the outer cortex
that could be TACs and non-proliferative 21-OH-positive cells
in the inner cortex, which are likely to be terminally
differentiated steroidogenic cells. Together, this suggests a
successively more differentiated cell hierarchy in which
subcapsular stem/progenitors and TACs in the outer cortex
maintain the differentiated adrenocortical zones.
Our investigations of cell proliferation and movement provide
evidence bearing on the different hypotheses proposed for
maintenance of the adult adrenal cortex, summarised in Figure
7. Data presented here for mouse and in the literature for rat, fit
well with the variant inward migration hypotheses outlined in
Figure 7A-C. All of these schemes require transdifferentiation
of inwardly moving steroidogenic cells from ZG to ZF/ZR, but
only version C is consistent with outward cell movement in the
outer cortex. The original zonal hypothesis (Figure 7D) can be
discounted because it does not take account of long-range
inward cell movement. Zonal variants proposing inward
movement from resident stem cell populations within
adrenocortical zones (Figure 7E, F) do not accord with pulse-
labelling patterns reported here or in whole-organ labelling [30],
as these hypotheses require cell movement from several points
of origin and predict that LRCs should occur in the ZF/ZR as
well as the ZG. Although proliferating cells around the mouse
ZG/ZF boundary and the rat ZI/ZU are most likely to be TACs,
this region could also contain either 1 or 2 populations of stem/
progenitor cells producing separate population of cells that
move outwards to maintain the ZG and inwards to maintain the
ZF/ZR (Figure 7G,H). However, the presence of BrdU LRCs in
the outer ZG but not in the central cortex or at the ZG/ZF
boundary, where stem cells would be predicted in hypotheses
D and E-H respectively (Figure 7), argues against this, at least
for mouse. The present observations can perhaps best be
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reconciled in the variant cell migration hypothesis shown in
Figure 7I in which one or two stem/progenitor cell populations
located in the subcapsular ZG and/or the capsule itself, support
lineage-committed TACs located around the ZG/ZF boundary,
which either differentiate into ZG cells, or move inwards to
become ZF/ZR cells. This is consistent with the observation in
rat of two distinct proliferative regions surrounding the ZI, which
may correspond to two TAC populations responding to different
circadian cues [25] and also with elegant lineage tracing
experiments favouring two distinct lineages of Shh-positive and
Gli1-positive steroidogenic progenitor cells during
adrenocortical development [17], possibly supported by a
capsular stem cell [1].
The suggestion of two distinct populations of lineage-
committed TACs responding to independent physiological
stimuli, accords with independent regulation of the adult
adrenocortical zones and ZG- and ZF-specific expression of
AS and 11β-OH, which allows the gland to respond to different
Figure 7.  Alternative hypotheses proposed for stem cell maintenance of the adrenal cortex.  Each hypothesis is modified to
include putative stem cells (blue stars) that produce TACs which divide, the offspring of which move in the direction of the vertical
arrows, gradually differentiating and eventually dying near the arrowheads. (A) Classical centripetal migration hypothesis: a single
stem cell population in the outer cortex gives rise to new TACs that displace existing cells inwards, transdifferentiating from ZG to
ZF to ZR to maintain all three zones (reviewed in 37); (B) Variant centripetal migration hypothesis: similar to (A), except that stem
cells are located in the adrenal capsule (reviewed in 1); (C) “Intermediate field” hypothesis: variant of (A) in which stem cells located
at the tips of looped strings of cells close to the ZG/ZI boundary, give rise to TACs that move along the strings, first outwards
towards the capsule and then arc around to move inwards, following a trajectory shaped like a ‘walking stick’ (reviewed in 37); (D)
Zonal hypothesis: each cortical zone is maintained independently by resident stem cells (reviewed in 37); (E) Independent inward
migration in three zones: variant of (D) with inward cell movement; (F) Independent inward migration in two zones: variant of (E)
where ZF and ZR are maintained by a single stem cell population; (G,H) ZI stem cells: where either two separate stem cell
populations or a single bipotential stem cell population in the ZI maintain both the ZG and ZF/ZR [2]; (I) Two separate lineages from
outer stem cells: variant hypothesis proposing that stem cells in the outer cortex or capsule produce TACs, which either differentiate
into ZG cells or move inwards to become ZF/ZR cells. The ZG and ZF/ZR lineages may be produced either by a single bipotential
population or two separate populations of stem/progenitor cells. Unlike (A-C), differentiated steroidogenic ZG cells do not
transdifferentiate into ZF/ZR cells.
doi: 10.1371/journal.pone.0081865.g007
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physiological demands. Thus, increased glucocorticoid
production regulated by the HPA axis in response to chronic
physiological stress is met in the ZF/ZR by increased cell
proliferation, hypertrophy and steroidogenic enzyme
expression, and reduced apoptosis. Similarly, ZG cells
numbers expressing AS are low under sodium-replete
conditions but increase following salt restriction, when renin-
angiotensin system-mediated aldosterone production is
required to promote sodium retention in the kidney. This
divergent physiological regulation indicates that several key
switches will be required to direct adrenocortical steroidogenic
progenitors to their appropriately differentiated fates.
Evidence for successive steps in steroidogenic cell
differentiation is also seen during both adrenocortical
development and regeneration. The key steroidogenic
transcription factor SF1 is first expressed in the mouse
adrenogonadal primordium around E9.5, while 21-OH is
detected around E11.5 specifically in the adrenal (but not the
gonadal) primordium, and 11β-OH and AS expression are first
seen respectively around E12.5 and E16.5, corresponding to
the onset of zonation [32–34]. Adrenocortical cell proliferation
following surgical enucleation is accompanied by reductions in
plasma corticosterone (requiring 21-OH and 11β-OH) and
aldosterone (requiring 21-OH and AS) and a transient increase
in deoxycorticosterone (requiring 21-OH, but neither 11β-OH
nor AS) [35,36]. These observations suggest an initial
proliferation of partially differentiated cells expressing 21-OH,
before re-expression of 11β-OH and AS following re-
establishment of zonation [36]. This is consistent with the idea
that partly differentiated TACs around the ZG/ZF boundary
express early steroidogenic pathway enzymes including 21-
OH, but that terminal differentiation is accompanied by
expression of either 11β-OH in the ZF/ZR or AS in the ZG.
Conclusions
The experiments reported here in the adult mouse adrenal
cortex provide evidence for (i) a population of proliferative cells
in the outer cortex that moves inwards through the ZF/ZR and
a second population in the outer cortex/ZG, representing either
slowly dividing progenitors or differentiated ZG cells that are
subsequently eliminated by apoptosis or redistribution to the
inner cortex following transdifferentiation; (ii) proliferative cells
in the outer cortex that could be TACs and non-proliferative 21-
OH-positive cells in the inner cortex, which may be terminally
differentiated steroidogenic cells; (iii) a subpopulation of BrdU-
pulse-chase-labelled cells in the outer cortex that lack
steroidogenic markers but divide in response to ACTH; and (iv)
LRCs remaining in the outer cortex that retain a BrdU label for
up to 18-23 weeks. These observations are consistent with a
model in which the adult mouse adrenal cortex is maintained
by slow-cycling stem/progenitors giving rise to partially
differentiated TACs that proliferate around the ZG/ZF
boundary, differentiate and move from the outer cortex to
replenish the three adrenocortical zones. If some of the
undifferentiated ACTH-responsive BrdU pulse-chase-labelled
cells are long term LRCs, they will be candidates for slow-
cycling subcapsular stem/progenitor cells.
Supporting Information
Figure S1.  Preliminary BrdU pulse-chase experiment to
optimise the chase period for identifying label-retaining
cells. (A-E) BrdU immunostaining of adrenal sections from
female F1 mice, (A) 4 hours, (B) 5 weeks, (C) 7 weeks, (D) 12
weeks and (E) 15 weeks following a 1-week BrdU infusion,
showing distributions of BrdU-labelled cells (identified by brown
nuclear staining). Scale = 100 µm. Abbreviations: c, capsule;
m, medulla.
(TIF)
Figure S2.  Distribution of BrdU-positive cells across the
adrenal cortex after different chase periods (preliminary
experiment). Quantitative results of a preliminary experiment
to optimise the chase period for identification of label-retaining
cells in adult mouse adrenal glands. The percentage of BrdU-
positive cells (identified by immunohistochemistry) in each row
of a 10 × 10 grid is shown after a 1-week exposure to BrdU
followed by chase periods of (A) 4 hours, (B) 5 weeks, (C) 7
weeks, (D) 12 weeks and (E) 15 weeks (1 mouse per chase
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